These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 26093664)

  • 1. Isoelectric Focusing of Serum Apolipoprotein C-III as a Sensitive Screening Method for the Detection of O-glycosylation Disturbances.
    Ondrušková N; Honzík T; Kytnarová J; Matoulek M; Zeman J; Hansíková H
    Prague Med Rep; 2015; 116(2):73-86. PubMed ID: 26093664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin and apolipoprotein C-III isofocusing are complementary in the diagnosis of N- and O-glycan biosynthesis defects.
    Wopereis S; Grünewald S; Huijben KM; Morava E; Mollicone R; van Engelen BG; Lefeber DJ; Wevers RA
    Clin Chem; 2007 Feb; 53(2):180-7. PubMed ID: 17170056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis.
    Wopereis S; Grünewald S; Morava E; Penzien JM; Briones P; García-Silva MT; Demacker PN; Huijben KM; Wevers RA
    Clin Chem; 2003 Nov; 49(11):1839-45. PubMed ID: 14578315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry of apolipoprotein C-III, a simple analytical method for mucin-type O-glycosylation and its application to an autosomal recessive cutis laxa type-2 (ARCL2) patient.
    Wada Y; Kadoya M; Okamoto N
    Glycobiology; 2012 Aug; 22(8):1140-4. PubMed ID: 22611120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups.
    Wopereis S; Morava E; Grünewald S; Adamowicz M; Huijben KM; Lefeber DJ; Wevers RA
    Glycobiology; 2005 Dec; 15(12):1312-9. PubMed ID: 16037491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALDI-TOF MS applied to apoC-III glycoforms of patients with congenital disorders affecting O-glycosylation. Comparison with two-dimensional electrophoresis.
    Yen-Nicolaÿ S; Boursier C; Rio M; Lefeber DJ; Pilon A; Seta N; Bruneel A
    Proteomics Clin Appl; 2015 Aug; 9(7-8):787-93. PubMed ID: 25641685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of N- and O-linked protein glycosylation in children with Prader-Willi syndrome.
    Munce T; Heussler HS; Bowling FG
    J Intellect Disabil Res; 2010 Oct; 54(10):929-37. PubMed ID: 20825553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria.
    Wopereis S; Abd Hamid UM; Critchley A; Royle L; Dwek RA; Morava E; Leroy JG; Wilcken B; Lagerwerf AJ; Huijben KM; Lefeber DJ; Rudd PM; Wevers RA
    Biochim Biophys Acta; 2006 Jun; 1762(6):598-607. PubMed ID: 16769205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate-deficient transferrin (CDT) as a biochemical tool for the screening of congenital disorders of glycosylation (CDGs).
    Biffi S; Tamaro G; Bortot B; Zamberlan S; Severini GM; Carrozzi M
    Clin Biochem; 2007 Dec; 40(18):1431-4. PubMed ID: 17920054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutis laxa with frontoparietal cortical malformation: a novel type of congenital disorder of glycosylation.
    Okanishi T; Saito Y; Yuasa I; Miura M; Nagata I; Maegaki Y; Ohno K
    Eur J Paediatr Neurol; 2008 May; 12(3):262-5. PubMed ID: 18187349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant apolipoprotein C-III glycosylation in glycogen storage disease type III and IX.
    Ondruskova N; Honzik T; Kolarova H; Pakanova Z; Mucha J; Zeman J; Hansikova H
    Metabolism; 2018 May; 82():135-141. PubMed ID: 29408683
    [No Abstract]   [Full Text] [Related]  

  • 12. Congenital disorders of N-glycosylation including diseases associated with O- as well as N-glycosylation defects.
    Leroy JG
    Pediatr Res; 2006 Dec; 60(6):643-56. PubMed ID: 17065563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical features in a Congolese infant with congenital disorder of glycosylation (CDG)-IIx.
    Nsibu NC; Jaeken J; Carchon H; Mampunza M; Sturiale L; Garozzo D; Mashako MN; Tshibassu MP
    Eur J Paediatr Neurol; 2008 May; 12(3):257-61. PubMed ID: 17884642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Our experience with diagnostics of congenital disorders of glycosylation.
    Ziad A; Eliska M; Hubert V; Lenka M; Petr D; Sylva S; Marika T; Jaroslava V; Eva R
    Acta Medica (Hradec Kralove); 2004; 47(4):267-72. PubMed ID: 15841907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient.
    Ondruskova N; Honzik T; Vondrackova A; Tesarova M; Zeman J; Hansikova H
    Neuro Endocrinol Lett; 2014; 35(2):137-41. PubMed ID: 24878975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of human plasma apolipoprotein C-III at birth and in early neonatal life.
    McConathy WJ; McCaffree MA; Lane DM
    J Lipid Res; 1987 Oct; 28(10):1193-8. PubMed ID: 3681143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein C-III O-glycoform profiling of 500 serum samples by matrix-assisted laser desorption/ionization mass spectrometry for diagnosis of congenital disorders of glycosylation.
    Wada Y; Okamoto N
    J Mass Spectrom; 2021 Apr; 56(4):e4597. PubMed ID: 32677746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A capillary zone electrophoresis method for detection of Apolipoprotein C-III glycoforms and other related artifactually modified species.
    Ruel C; Morani M; Bruneel A; Junot C; Taverna M; Fenaille F; Tran NT
    J Chromatogr A; 2018 Jan; 1532():238-245. PubMed ID: 29221866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common mutation in the COG7 gene with a consistent phenotype including microcephaly, adducted thumbs, growth retardation, VSD and episodes of hyperthermia.
    Morava E; Zeevaert R; Korsch E; Huijben K; Wopereis S; Matthijs G; Keymolen K; Lefeber DJ; De Meirleir L; Wevers RA
    Eur J Hum Genet; 2007 Jun; 15(6):638-45. PubMed ID: 17356545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms.
    Trenchevska O; Schaab MR; Nelson RW; Nedelkov D
    Methods; 2015 Jun; 81():86-92. PubMed ID: 25752847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.